PR
Alterity Therapeutics Limited
PRNAF · OTC
$0.06 +0.00% (+$0.00)
Market Cap $17.3M
P/E Ratio -
Div. Yield -
ROE 141.08%
Piotroski F-Score Weak
3/9Valuation
85 /100
Cheap P/S 2.30x
P/B 0.41x
P/E N/A
Growth
100 /100
Growing Book val. growth 29.32%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 95.89%
FCF margin 265.48%
Net margin 381.67%
Quality
2 /100
Poor ROIC 72.18%
Asset turnover 0.16x
ROE 141.08%
Debt
94 /100
Low Debt/Equity 0.00x
Net debt/EBITDA 1.08x
Current ratio 12.98x
Stability
49 /100
Moderate Beta -0.04x
Profitable years 0
EPS volatility 27.78%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PRNAF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David A. Stamler
Employees
11
Headquarters
Melbourne
Prihajajoči dogodki
04 MAR.
Earnings
Upcoming earnings report